Effects of Maternal Omega-3 Supplementation on Systemic Inflammation and Early Infant Neurodevelopment: A Prospective Comparative Study in Pakistan
Omega-3 and Infant Neurodevelopment
DOI:
https://doi.org/10.69750/dmls.02.03.0112Keywords:
DHA, EPA, pregnancy, inflammation, neurodevelopment, cognition, Omega-3 fatty acidsAbstract
Background: Long-chain omega-3 polyunsaturated fatty acids (PUFAs), notably docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), support fetal neurogenesis and attenuate maternal inflammation. In South Asia, dietary omega-3 intake is low and pregnancy-related data are scarce.
Objectives: To evaluate the impact of maternal omega-3 supplementation on third-trimester inflammatory biomarkers, neonatal cranial ultrasound measures, and 12-month cognitive outcomes.
Methods: In this prospective comparative study, 40 women at 20–22 weeks’ gestation were enrolled at tertiary hospitals in Pakistan (September 2023–December 2024). Participants self-selected into two groups: supplemented (n = 20; ≥ 500 mg DHA + 120 mg EPA daily from enrollment until delivery) and control (n = 20; no supplementation). At 32–34 weeks, fasting blood samples were analyzed for interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) via ELISA. Within 48 hours of birth, cranial ultrasound assessed head circumference, biparietal diameter, and lateral-ventricle width. At 12 months, cognitive performance was measured using the Bayley Scales of Infant Development, Third Edition (BSID-III). Statistical analyses included independent-samples t-tests, Mann–Whitney U tests, chi-square or Fisher’s exact tests, and Pearson correlation; significance was set at p < 0.05.
Results: Supplemented women exhibited lower IL-6 (3.8 ± 1.1 vs. 5.4 ± 1.3 pg/mL; p = 0.001) and CRP (2.1 ± 0.6 vs. 3.6 ± 1.0 mg/L; p = 0.0002). Their infants had larger head circumferences (34.8 ± 1.1 vs. 33.7 ± 1.3 cm; p = 0.004) and greater biparietal diameters (92.4 ± 2.6 vs. 89.5 ± 2.9 mm; p = 0.001). At 12 months, cognitive composite scores were higher in the supplemented group (109.2 ± 7.6 vs. 101.7 ± 8.4; p = 0.002). Maternal CRP inversely correlated with cognitive scores (r = –0.48; p = 0.004).
Conclusions: Maternal omega-3 supplementation during pregnancy significantly reduces systemic inflammation and enhances early neurodevelopmental outcomes. Routine prenatal omega-3 supplementation is recommended, particularly in low-intake populations.
Downloads
References
Larqué E, Gil-Sánchez A, Prieto-Sánchez MT, Koletzko B. Omega 3 fatty acids, gestation and pregnancy outcomes. British Journal of Nutrition. 2012;107(S2):S77-S84.doi: 10.1017/S0007114512001481
Labrousse VF, Leyrolle Q, Amadieu C, Aubert A, Sere A, Coutureau E, et al. Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation. Brain, Behavior, and Immunity. 2018;73:427-40.doi: https://doi.org/10.1016/j.bbi.2018.06.004
Nevins JEH, Donovan SM, Snetselaar L, Dewey KG, Novotny R, Stang J, et al. Omega-3 Fatty Acid Dietary Supplements Consumed During Pregnancy and Lactation and Child Neurodevelopment: A Systematic Review. The Journal of Nutrition. 2021;151(11):3483-94.doi: https://doi.org/10.1093/jn/nxab238
Devarshi PP, Grant RW, Ikonte CJ, Hazels Mitmesser S. Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia. Nutrients [Internet]. 2019; 11(5).doi: 10.3390/nu11051107
Chowdhury MH, Susmita G, Ruhul KM, Al MMA, and Islam MS. Effect of supplementary omega-3 fatty acids on pregnant women with complications and pregnancy outcomes: review from literature. The Journal of Maternal-Fetal & Neonatal Medicine. 2022;35(13):2564-80.doi: 10.1080/14767058.2020.1786522
Klemens CM, Berman DR, Mozurkewich EL. The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2011;118(8):916-25.doi: https://doi.org/10.1111/j.1471-0528.2010.02846.x
Li J, Yin H, Bibus DM, Byelashov OA. The role of Omega-3 docosapentaenoic acid in pregnancy and early development. European Journal of Lipid Science and Technology. 2016;118(11):1692-701.doi: https://doi.org/10.1002/ejlt.201600076
Tahaei H, Gignac F, Pinar A, Fernandez-Barrés S, Romaguera D, Vioque J, et al. Omega-3 Fatty Acid Intake during Pregnancy and Child Neuropsychological Development: A Multi-Centre Population-Based Birth Cohort Study in Spain. Nutrients [Internet]. 2022; 14(3).doi: 10.3390/nu14030518
Sun J, Zhang W. Supplementation with dietary omega-3 PUFA mitigates fetal brain inflammation and mitochondrial damage caused by high doses of sodium nitrite in maternal rats. PLOS ONE. 2022;17(3):e0266084.doi: 10.1371/journal.pone.0266084
Basak S, Mallick R, Duttaroy AK. Maternal Docosahexaenoic Acid Status during Pregnancy and Its Impact on Infant Neurodevelopment. Nutrients [Internet]. 2020; 12(12).doi: 10.3390/nu12123615
Leyrolle Q, Decoeur F, Briere G, Amadieu C, Quadros ARAA, Voytyuk I, et al. Maternal dietary omega-3 deficiency worsens the deleterious effects of prenatal inflammation on the gut-brain axis in the offspring across lifetime. Neuropsychopharmacology. 2021;46(3):579-602.doi: 10.1038/s41386-020-00793-7
Gustafsson HC, Holton KF, Anderson AN, Nousen EK, Sullivan CA, Loftis JM, et al. Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect. Frontiers in Neuroscience. 2019;Volume 13 - 2019.doi: 10.3389/fnins.2019.01035
Haghiac M, Yang X-h, Presley L, Smith S, Dettelback S, Minium J, et al. Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial. PLOS ONE. 2015;10(9):e0137309.doi: 10.1371/journal.pone.0137309
Delattre AM, Carabelli B, Mori MA, Kempe PG, Rizzo de Souza LE, Zanata SM, et al. Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson’s Disease Model. Molecular Neurobiology. 2017;54(3):2090-106.doi: 10.1007/s12035-016-9803-8
Rees G, Brough L, Orsatti GM, Lodge A, Walker S. Do Micronutrient and Omega-3 Fatty Acid Supplements Affect Human Maternal Immunity during Pregnancy? A Scoping Review. Nutrients [Internet]. 2022; 14(2).doi: 10.3390/nu14020367
Sley EG, Rosen EM, van ‘t Erve TJ, Sathyanarayana S, Barrett ES, Nguyen RHN, et al. Omega-3 fatty acid supplement use and oxidative stress levels in pregnancy. PLOS ONE. 2020;15(10):e0240244.doi: 10.1371/journal.pone.0240244
Shahabi B, Hernández-Martínez C, Voltas N, Canals J, Arija V. The Maternal Omega-3 Long-Chain Polyunsaturated Fatty Acid Concentration in Early Pregnancy and Infant Neurodevelopment: The ECLIPSES Study. Nutrients [Internet]. 2024; 16(5).doi: 10.3390/nu16050687
Marx W, Thomson S, O'Hely M, Symeonides C, Collier F, Tang MLK, et al. Maternal inflammatory and omega-3 fatty acid pathways mediate the association between socioeconomic disadvantage and childhood cognition. Brain, Behavior, and Immunity. 2022;100:211-8.doi: https://doi.org/10.1016/j.bbi.2021.12.002
Firouzabadi FD, Shab-Bidar S, Jayedi A. The effects of omega-3 polyunsaturated fatty acids supplementation in pregnancy, lactation, and infancy: An umbrella review of meta-analyses of randomized trials. Pharmacological Research. 2022;177:106100.doi: https://doi.org/10.1016/j.phrs.2022.106100
Saccone G, Irene S, and Berghella V. Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(15):2389-97.doi: 10.3109/14767058.2015.1086742
Downloads
PlumX Metrics
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
© The Author(s) 2025. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
